• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Babylon Announces Integrated Digital-First Chronic Condition Programs Offering Personalized Evidence-Based Care Within Single Interface

    3/15/23 8:00:00 AM ET
    $BBLN
    Medical/Nursing Services
    Health Care
    Get the next $BBLN alert in real time by email
    • Chronic conditions include diabetes, hypertension, anxiety, depression, low back pain, and prenatal care
    • Babylon's technology will collect and analyze data to monitor patients in real-time
    • Personalized care teams will tailor evidence-based programs for each member
    • Care is integrated into Babylon's single platform for a seamless experience for both providers and members

    Babylon (NYSE:BBLN), a global digital healthcare company, announced today personalized, digital-first programs for high-risk members living with chronic conditions. The care pathways were developed hand-in-hand by Babylon's expert technologists and primary care teams for a true end-to-end value-based care system. The programs are offered as part of Babylon's integrated primary care model that collects and analyzes data to monitor members in real time as they manage many conditions.

    Conditions in the program include: diabetes, hypertension, low back pain, prenatal care, anxiety, and depression programs. Babylon's technology will collect and analyze members' data allowing providers to monitor and intervene sooner. Multidisciplinary care teams will support members in managing chronic conditions and deliver high-quality, evidence-based care to members.

    "A digital-first chronic condition program may improve patient health and decrease the rate of acute events and associated hospitalizations. At Babylon, we have worked hard to bring personalized, evidence-based care for a number of conditions together under a single interface to the patient," said Dr. Darshak Sanghavi, Global Chief Medical Officer at Babylon. "We think hard about our patients and want them to have a way to receive regular health education, monitor symptoms and seek advice, and get the right care that goes beyond just the meeting with their clinician. We are providing evidence-based programs for how to do that and giving patients access to tools that will provide an engaging and enjoyable way to better engage in their own health."

    For example, in Babylon's prenatal care, the program engages pregnant women with regular touchpoints and digital tools on a week-by-week journey to assist with prevention and care during pregnancy. There are more than two million women of child-bearing age living in maternity deserts, and the U.S. has the highest maternal mortality rate among developed countries - roughly four out of five pregnancy related deaths are preventable. Babylon is delivering side-by-side digital and clinical services including both pregnancy education, actionable to-do's, mental wellbeing screening and more through our integrated digital care journey.

    "It's so important that we offer a service to women who are pregnant or shortly after birth and engage with these women," Dr. Kimya Tarr, Senior Digital Health Manager at Babylon. "If we are able to break down barriers to care and help the mother get the care she needs, it's more likely the baby will be healthy, and we will have reduced the cost for the mother and the newborn."

    In Babylon's diabetes journey, the care team supports the patient to create a personalized care plan based on the patient's assessment. The structured journey includes in-app digital content and three planned virtual touchpoints to track progress, and may be expanded to additional touchpoints based on the needs of the patient. The care team ensures the patient is up to date on all recommended screenings, immunizations, and labs; and any abnormalities are evaluated with the support of the primary care provider. Care goals are adjusted as needed. This model is based on the American Diabetes Association recommendation to provide Diabetes Self Management Education and Support, which empowers patients to implement and sustain self-management of their condition. Participation in DSMES has been shown to lower blood sugar measurements as much as any medication, lower the risk of complications and improve health outcomes. Diabetes affects more than 30 million U.S. adults and children (>11% of the population), and only about 1 million people receive DSMES services annually.

    "We're providing populations living with diabetes in rural areas with the tools to self-monitor, support to access preventive screenings and immunizations and access to 24/7 primary care through our digital platform," said Dr. Amber Featherstone, Digital Health Principal at Babylon. "Through implementing the DSMES program, we are employing an underutilized resource to improve patient outcomes and cut the costs of care."

    All chronic condition management programs are available to B360 members with additional programs planned for the future.

    About Babylon

    At Babylon, our mission is to make quality healthcare accessible and affordable for every person on Earth. To this end we are building an integrated digital first primary care service that can manage population health at scale. Founded in 2013, we are reengineering how people engage with their care at every step of the healthcare continuum. Today, Babylon's technology and clinical services support a global patient network across 15 countries, and our digital healthcare platform is capable of operating in 16 languages. Babylon is also working with governments, health providers, employers and insurers across the globe to provide them with a new digital-first platform that any partner can use to deliver high-quality healthcare with lower costs and better outcomes. For more information, please visit www.babylonhealth.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230315005109/en/

    Get the next $BBLN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BBLN

    DatePrice TargetRatingAnalyst
    3/16/2023Buy → Neutral
    BTIG Research
    1/5/2023$4.00 → $20.00Buy
    BTIG Research
    6/23/2022$2.00Neutral
    BofA Securities
    4/28/2022$5.50Hold
    Berenberg
    1/12/2022$9.00Buy
    Deutsche Bank
    12/7/2021$8.00Neutral
    Citigroup
    12/2/2021$14.00Buy
    Canaccord Genuity
    12/2/2021$9.00Hold
    Jefferies
    More analyst ratings

    $BBLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Vnv Global Ab (Publ)

      4 - Babylon Holdings Ltd (0001866390) (Issuer)

      6/30/23 4:18:26 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form 4 filed by Vnv Global Ab (Publ)

      4 - Babylon Holdings Ltd (0001866390) (Issuer)

      6/28/23 5:29:39 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form 4 filed by Vnv (Cyprus) Ltd

      4 - Babylon Holdings Ltd (0001866390) (Issuer)

      6/26/23 6:25:34 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    SEC Filings

    See more
    • Babylon Holdings Limited filed SEC Form 8-K: Other Events

      8-K - Babylon Holdings Ltd (0001866390) (Filer)

      8/31/23 5:18:08 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Holdings Limited filed SEC Form 8-K: Other Events

      8-K - Babylon Holdings Ltd (0001866390) (Filer)

      8/11/23 5:01:17 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form NT 10-Q filed by Babylon Holdings Limited

      NT 10-Q - Babylon Holdings Ltd (0001866390) (Filer)

      8/10/23 5:21:19 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Babylon Proceeds With Previously Announced Transaction and Announces the Receipt of Continued Listing Standards Notice from NYSE and Upcoming Delisting

      Babylon Holdings Limited (the "Company" or "Babylon") (NYSE:BBLN) previously announced in its June 23, 2023 press release that the Company has received a proposal from AlbaCore Capital LLP ("AlbaCore") and MindMaze Group SA ("MindMaze") pursuant to which core operating subsidiaries of the Company would be transferred to MindMaze (the "Proposed Transaction"). The closing of the Proposed Transaction is expected in July 2023 and is subject to agreed documentation, various conditions and appropriate approvals, if required. The Proposed Transaction will not provide for any payment to the Company's Class A ordinary shareholders or other equity instrument holders, as AlbaCore will be exercising ri

      6/28/23 4:30:00 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Announces Update on Take Private Proposal

      After a thorough exploration of strategic alternatives, Babylon Holdings Limited (NYSE:BBLN) (including its subsidiaries, "Babylon") is pleased to provide an update on the recapitalization transaction, previously announced on May 10, following receipt of a proposal from AlbaCore Capital LLP on behalf of certain of its affiliates ("AlbaCore") and MindMaze Group SA ("MindMaze"), and share that Babylon has selected the previously announced take private proposal from the options considered. The proposal strongly positions Babylon to accelerate its core mission – to make high quality healthcare more accessible and affordable by combining the most cutting-edge technology with the best medical ex

      6/23/23 6:00:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Reports Q1 2023 Financial Results

      Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company") today announced its financial and operating results for the first quarter ended March 31, 2023. First Quarter Financial Results Comparison of the following financial results for the three months ended March 31, 2023, to the three months ended March 31, 2022: Total revenue was $311.1 million compared to $266.4 million, a 1.2x year-over-year increase of $44.7 million. This was primarily due to the growth in VBC revenue, which increased by 17% year-over-year to $287.5 million in Q1 2023. Net loss totaled $63.2 million, a (20.3)% Net loss margin compared to Net loss of $29.1 million, a (10.9)% Net loss margin in Q1 2022

      5/10/23 6:01:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Babylon downgraded by BTIG Research

      BTIG Research downgraded Babylon from Buy to Neutral

      3/16/23 7:14:08 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • BTIG Research reiterated coverage on Babylon with a new price target

      BTIG Research reiterated coverage of Babylon with a rating of Buy and set a new price target of $20.00 from $4.00 previously

      1/5/23 9:37:21 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • BofA Securities initiated coverage on Babylon with a new price target

      BofA Securities initiated coverage of Babylon with a rating of Neutral and set a new price target of $2.00

      6/23/22 9:05:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Leadership Updates

    Live Leadership Updates

    See more
    • Babylon Appoints David Humphreys as Chief Financial Officer

      Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company"), one of the world's fastest growing digital healthcare companies, announces that David Humphreys will be appointed as the Company's new Chief Financial Officer. Mr. Humphreys has been at Babylon for nearly two years in the role of Finance Director, with overall responsibility for building and scaling Babylon's finance function. Formerly, he was US-based as a Silicon Valley and New York Partner with PwC for over 20 years, working with Boards and leaders of fast-moving, rapid-growth companies including Tesla and Facebook to which he provided accounting consulting, transaction, IPO, M&A and auditing services to ensure complianc

      8/23/22 5:10:00 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Financials

    Live finance-specific insights

    See more
    • Babylon Reports Q1 2023 Financial Results

      Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company") today announced its financial and operating results for the first quarter ended March 31, 2023. First Quarter Financial Results Comparison of the following financial results for the three months ended March 31, 2023, to the three months ended March 31, 2022: Total revenue was $311.1 million compared to $266.4 million, a 1.2x year-over-year increase of $44.7 million. This was primarily due to the growth in VBC revenue, which increased by 17% year-over-year to $287.5 million in Q1 2023. Net loss totaled $63.2 million, a (20.3)% Net loss margin compared to Net loss of $29.1 million, a (10.9)% Net loss margin in Q1 2022

      5/10/23 6:01:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Announces First Quarter 2023 Earnings Conference Call

      Babylon (NYSE:BBLN) (the "Company") today announced it will host a conference call to review its first quarter financial results on Wednesday, May 10, 2023, at 8:00 AM Eastern Time. A press release announcing the results will be issued prior to the conference call on Wednesday, May 10, 2023. To participate in the live conference call and webcast, please dial (877) 407-7994 for U.S. participants, 0 800 756 3429 for U.K. participants or +1 215-268-9868 for international participants. Alternatively, you can visit the "News & Events" section of https://ir.babylonhealth.com to access the live webcast. On this page, you can also find a "Call me" link for instant telephone access to the event, w

      4/19/23 6:00:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Reports Another Strong Year Exceeding Guidance, and Accelerates Expected Adjusted EBITDA Profitability to Mid-2024

      Revenue grew 3.5x YoY, to $1.11 billion, exceeding guidance Cost of Care Delivery (COCD) Margin in the U.K. already profitable1, with U.S. Clinical services also expecting COCD profitability in early 2023 Key U.S. VBC contracts delivered profitable Medical Margins2 in their first year Monthly Adjusted EBITDA of $(16.3) million for Q4 2022 beating guidance of $(18) million Adjusted EBITDA profitability expected in mid-2024, significantly earlier than previous guidance Commercial VBC revenue substantially increased with recent launch of Ambetter digital-first service across 6 states Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company") today announced its financial an

      3/9/23 6:00:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Babylon Holdings Limited (Amendment)

      SC 13D/A - Babylon Holdings Ltd (0001866390) (Subject)

      6/29/23 5:26:01 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Babylon Holdings Limited (Amendment)

      SC 13G/A - Babylon Holdings Ltd (0001866390) (Subject)

      2/14/23 11:54:33 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Babylon Holdings Limited (Amendment)

      SC 13G/A - Babylon Holdings Ltd (0001866390) (Subject)

      11/14/22 4:08:50 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care